Evidence map›Paper›PMID 30670663›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Microbe-focused glycan array screening platform.

Andreas Geissner, Anika Reinhardt, Christoph Rademacher, Timo Johannssen, João Monteiro, Bernd Lepenies, Michel Thépaut, Franck Fieschi, Jana Mrázková, Michaela Wimmerova and 17 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Automated Synthesis of Algal Fucoidan Oligosaccharides.Journal of the American Chemical Society · 2024
    Article
  12. A Fluorinated Sialic Acid Vaccine Lead Against Meningitis B and C.Journal of the American Chemical Society · 2024
    Article
  13. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 3 countries.

Andreas GeissnerDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Anika ReinhardtDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Christoph RademacherDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.ORCID 0000-0001-7082-7239
Timo JohannssenDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
João MonteiroImmunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.ORCID 0000-0002-9855-7485
Bernd LepeniesDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Michel ThépautUniversité Grenoble Alpes, Institut de Biologie Structurale, F-38044 Grenoble, France.
Franck FieschiUniversité Grenoble Alpes, Institut de Biologie Structurale, F-38044 Grenoble, France.ORCID 0000-0003-1194-8107
Jana MrázkováCentral European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Michaela WimmerovaCentral European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0002-7108-4198
Frank SchuhmacherDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.ORCID 0000-0002-2586-4118
Sebastian GötzeDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.ORCID 0000-0002-4087-0225
Dan GrünsteinDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Xiaoqiang GuoDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Heung Sik HahmDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.ORCID 0000-0003-2326-7923
Jeyakumar KandasamyDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Daniele LeonoriDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Christopher E MartinDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Sharavathi G ParameswarappaDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Sandip PasariDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Mark K SchlegelDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Hidenori TanakaDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Guozhi XiaoDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
You YangDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.ORCID 0000-0003-4438-2162
Claney L PereiraDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Chakkumkal AnishDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany.
Peter H SeebergerDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany; peter.seeberger@mpikg.mpg.de.ORCID 0000-0003-3394-8466
Max Planck Institute of Colloids and Interfaces · DECentral European Institute of Technology · CZCentre National de la Recherche Scientifique · FRUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interactions between glycans and glycan binding proteins are essential for numerous processes in all kingdoms of life. Glycan microarrays are an excellent tool to examine protein-glycan interactions. Here, we present a microbe-focused glycan microarray platform based on oligosaccharides obtained by chemical synthesis. Glycans were generated by combining different carbohydrate synthesis approaches including automated glycan assembly, solution-phase synthesis, and chemoenzymatic methods. The current library of more than 300 glycans is as diverse as the mammalian glycan array from the Consortium for Functional Glycomics and, due to its microbial focus, highly complementary. This glycan platform is essential for the characterization of various classes of glycan binding proteins. Applications of this glycan array platform are highlighted by the characterization of innate immune receptors and bacterial virulence factors as well as the analysis of human humoral immunity to pathogenic glycans.

Indexed as

AnimalsAntigens, BacterialCarrier ProteinsCHO CellsCricetulusGlycomicsHumansImmune SystemLectinsMicroarray AnalysisOligosaccharidesPolysaccharidesProtein BindingRecombinant ProteinsSpecies SpecificityAntigens, BacterialCarrier ProteinsLectinsOligosaccharidesPolysaccharidesRecombinant Proteinsantiglycan antibodiesbacterial lectinsglycan arraysimmune receptorsmicrobial antigens

Identifiers

PMID30670663
PMCPMC6369816
OpenAlexW2912086383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.